Skip to main content

Table 1 Summary of clinicopathological factors of patients invovled in this study

From: Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma

Factors

Categories

Number (%)

Sex (%)

Female

47 (28.8)

 

Male

116 (71.2)

Age (mean (SD))

 

60.31 (12.11)

Race (%)

Asian

78 (47.8)

 

Black or African American

7 (4.3)

 

Not reported

6 (3.7)

 

White

72 (44.2)

TMB (mean (SD))

 

1.52 (1.03)

Neoplasm histologic grade (%)

G1

25 (15.3)

 

G2

75 (46.0)

 

G3

52 (31.9)

 

G4

11 (6.7)

Adjacent hepatic tissue inflammation (%)

None

55 (33.7)

 

Mild or severe

56 (34.4)

 

Not reported

52 (31.9)

Child Pugh classification grade (%)

A

118 (72.4)

 

B or C

10 (6.1)

 

Not reported

35 (21.5)

Fibrosis Ishak score (%)

0: No fibrosis

28 (17.2)

 

1, 2: Portal fibrosis

18 (11.0)

 

3, 4: Fibrous speta

13 (8.0)

 

5: Nodular formation and incomplete cirrhosis

1 (0.6)

 

6: Established cirrhosis

42 (25.8)

 

Not reported

61 (37.4)

Creatinine (%)

Normal

114 (69.9)

 

High

8 (4.9)

 

Low

26 (16.0)

 

Not reported

15 (9.2)

Platelet (%)

Normal

109 (66.9)

 

High

4 (2.5)

 

Low

39 (23.9)

 

Not reported

11 (6.7)

Albumin (%)

Normal

114 (7.0)

 

High

1 (0.6)

 

Low

33 (20.2)

 

Not reported

15 (9.2)

  1. TMB, tumor mutational burden; G, grade; SD, standard deviation